The company's intismeran product requires a unique and complex manufacturing process for each patient, creating a significant risk of production challenges. This highlights a need for advanced manufacturing execution systems (MES), quality management, and supply chain solutions tailored for personalized medicine.
Filing excerpt
Our intismeran autogene product candidates are uniquely manufactured for each patient using a novel, complex manufacturing process and we may encounter difficulties in production;
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Vendors
sec-10kmanufacturingIssueGet every 10-K signal for Moderna and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/db86aecb-5ca4-4bc9-99dd-d5d50c6deb06 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.
{
"signal_id": "db86aecb-5ca4-4bc9-99dd-d5d50c6deb06",
"signal_type": "sec-10k",
"signal_subtype": "manufacturingIssue",
"detected_at": "2026-02-24T09:33:59.024+00:00",
"company": {
"name": "Moderna",
"domain": "modernatx.com"
},
"data": {
"detail": "The company's intismeran product requires a unique and complex manufacturing process for each patient, creating a significant risk of production challenges. This highlights a need for advanced manufacturing execution systems (MES), quality management, and supply chain solutions tailored for personalized medicine.",
"summary": "Moderna flags production difficulties for its personalized cancer therapy, intismeran.",
"excerpts": "Our intismeran autogene product candidates are uniquely manufactured for each patient using a novel, complex manufacturing process and we may encounter difficulties in production;",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/mrna-20251231.htm",
"filing_date": "2026-02-20",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Operations optimization needed",
"signal_category": "operations",
"vendors_mentioned": [
"Merck",
"Recordati"
],
"technologies_mentioned": [
"mRNA"
]
}
}
curl https://signals.autobound.ai/v1/signals/db86aecb-5ca4-4bc9-99dd-d5d50c6deb06 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"modernatx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.